Chemomab Therapeutics Ltd...

NASDAQ: CMMB · Real-Time Price · USD
0.94
0.04 (4.76%)
At close: Aug 15, 2025, 3:58 PM
0.95
1.58%
After-hours: Aug 15, 2025, 07:26 PM EDT

Chemomab Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
53.25K 66.83K 57.77K 34.02K
Gross Profit
n/a -66.83K -57.77K -34.02K
Operating Income
-14.74K -25.46M -28.53M -12.37M
Interest Income
797.77K 1.24M 351.62K 65.00
Pretax Income
-13.95K -24.22M -28.18M -12.48M
Net Income
-13.95K -24.22M -27.65M -12.48M
Selling & General & Admin
3.41K 7.08M 11.56M 6.03M
Research & Development
11.33K 18.38M 16.98M 6.33M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
14.74K 25.46M 28.53M 12.37M
Interest Expense
n/a n/a 353K 111.08K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
14.74K 25.46M 28.53M 12.37M
Income Tax Expense
n/a n/a -534K 77K
Shares Outstanding (Basic)
17.95M 11.75M 11.38M 10.37M
Shares Outstanding (Diluted)
17.95M 11.75M 11.38M 10.37M
EPS (Basic)
-0.78 -2.06 -2.42 -1.2
EPS (Diluted)
-0.78 -2.06 -2.42 -1.2
EBITDA
-14.67K -25.39M -28.48M -12.33M
EBIT
-14.74K -25.46M -28.53M -12.37M
Depreciation & Amortization
53.25K 67K 57.77K 34.02K